Jason Cavalier - Chief Financial Officer at Lyra Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
LYRA on Nasdaq
All Insider Reports
All Insider Reports

Jason Cavalier - trading volume in the past year for Lyra Therapeutics, Inc.

Holdings reported by Jason Cavalier for Lyra Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 518,547 $1,744,392 $3.36 06 Jan 2026 Direct

Transactions reported by Jason Cavalier for Lyra Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.